Reuters

CDC advisers to review data on Pfizer-BioNTech COVID-19 vaccine

(Reuters) - A U.S. Centers for Disease Control and Prevention (CDC) advisory panel will meet on Friday to review data on the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE, with a vote ...
Becker's Hospital Review

Pfizer-BioNTech vaccine doesn’t need to be adapted for variants, drugmaker says

BioNTech said May 10 there is “no evidence” supporting the need to adapt the COVID-19 vaccine it developed with Pfizer to be more effective against coronavirus variants. As international COVID-19 ...
RAPS

CHMP starts rolling review of Pfizer/BioNTech COVID vaccine

A second candidate vaccine against COVID-19 is undergoing rolling review by the European Medicines Agency (EMA), as the agency begins with evaluation of pre-clinical data to support approval of a ...
Time

How the First COVID-19 Vaccinations Rolled Out at Hospitals Across the U.S.

Just before 9:30 a.m. on Monday, Sandra Lindsay, an intensive care nurse at Long Island Jewish Medical Center in Queens, New York, became one of the first people to get vaccinated against COVID-19.
RAPS

Recon: EMA starts rolling review of Pfizer-BioNTech variant vaccine; Pfizer halts Paxlovid study enrollment for lower-risk population

Regulatory Recon is our daily intelligence briefing for the regulatory affairs space, bringing you the top regulatory, biopharma and medtech news stories from around the globe. A story’s inclusion in ...
Nasdaq

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the XFG and NB.1.8.1 variants1 – compared to ...